Efficacy and safety of oral NEPA versus fosaprepitant combined with palonosetron for preventing highly emetogenic chemotherapy-induced nausea and vomiting in patients with nasopharyngeal carcinoma.

Authors: Haiqing Luo, Yilin Cai, Ying Zeng, Guihua Yi, Donghong Yang, Tongyuan Deng, Haiwen Li, Qihang Li

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18075

Source: Full article

e18075